Campbell & CO Investment Adviser LLC

Position in LLY — ELI LILLY & Co

CIK 1353570 BALTIMORE, MD

Position in LLY

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$4,416,301

-$2,059,799 QoQ

Shares Held

3,682

-47.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#1,808

of 4,605 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $29,426,907 across 9 Drug Manufacturers - General names. LLY ranks #3 (15.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	18,379	$6,655,403
2	AZN	Astrazeneca PLC	29,025	$5,503,720
3	LLY	ELI LILLY & Co This page	3,682	$4,416,301
4	GSK	GSK plc	83,989	$4,402,703
5	SNY	Sanofi	52,949	$2,258,804
6	GILD	Gilead Sciences, Inc.	17,781	$2,246,451
7	PFE	Pfizer Inc	75,099	$1,808,383
8	BMY	Bristol Myers Squibb Co	23,327	$1,344,101

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,416,301	3,682	-47.7%	Shares	Sole	2026-08-03
2026-03-31	$6,476,100	7,041	+138.7%	Shares	Sole	2026-05-15
2025-12-31	$3,170,306	2,950	-14.0%	Shares	Sole	2026-02-12
2025-09-30	$2,618,616	3,432	+153.1%	Shares	Sole	2025-10-28
2025-03-31	$1,119,933	1,356	+78.9%	Shares	Sole	2025-05-14
2024-09-30	$671,542	758	-92.3%	Shares	Sole	2024-11-12
2024-06-30	$8,884,493	9,813	+915.8%	Shares	Sole	2024-08-13
2024-03-31	$751,509	966	+122.1%	Shares	Sole	2024-05-10
2023-09-30	$233,651	435	-57.7%	Shares	Sole	2023-11-08
2022-06-30	$333,632	1,029	-86.8%	Shares	Sole	2022-08-09
2022-03-31	$2,225,667	7,772	+10.9%	Shares	Sole	2022-05-09
2021-09-30	$1,619,660	7,010	+240.3%	Shares	Sole	2021-11-10
2021-03-31	$384,849	2,060	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.